About Radiance Therapeutics
Radiance Therapeutics is a company based in Oro Valley (United States) founded in 2018.. Radiance Therapeutics has raised $14 million across 3 funding rounds. Radiance Therapeutics operates in a competitive market with competitors including ViaLase, BELKIN Vision, ELIOS Vision and EyeLight, among others.
- Headquarter Oro Valley, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Radiance Therapeutics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$14 M (USD)
in 3 rounds
-
Latest Funding Round
$4.29 M (USD), Series B
Jan 20, 2022
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Radiance Therapeutics
Radiance Therapeutics has successfully raised a total of $14M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $4.29 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $4.3M
-
First Round
First Round
(22 Jan 2019)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2022 | Amount | Series B - Radiance Therapeutics | Valuation |
investors |
|
| Oct, 2020 | Amount | Series B - Radiance Therapeutics | Valuation |
investors |
|
| Jan, 2019 | Amount | Series A - Radiance Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Radiance Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Radiance Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Radiance Therapeutics Comparisons
Competitors of Radiance Therapeutics
Radiance Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ViaLase, BELKIN Vision, ELIOS Vision and EyeLight, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Image-guided femtosecond laser devices for glaucoma treatments are developed.
|
|
| domain | founded_year | HQ Location |
Laser device for glaucoma treatment developed by BELKIN Vision.
|
|
| domain | founded_year | HQ Location |
Excimer laser technology is applied to develop glaucoma therapy devices.
|
|
| domain | founded_year | HQ Location |
Develops patented treatment methods for glaucoma.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Radiance Therapeutics
Frequently Asked Questions about Radiance Therapeutics
When was Radiance Therapeutics founded?
Radiance Therapeutics was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Where is Radiance Therapeutics located?
Radiance Therapeutics is headquartered in Oro Valley, United States. It is registered at Oro Valley, Arizona, United States.
Is Radiance Therapeutics a funded company?
Radiance Therapeutics is a funded company, having raised a total of $14M across 3 funding rounds to date. The company's 1st funding round was a Series A of $3.53M, raised on Jan 22, 2019.
What does Radiance Therapeutics do?
Radiance Therapeutics was founded in 2018 in Oro Valley, United States, within the medical device sector focused on ophthalmology. A beta ophthalmic applicator is being developed to manage glaucoma surgically by down-regulating Tenons capsule fibroblasts. Topical beta therapy is applied to sites of trabeculectomy and drainage device implantation. Operations center on device innovation for improved surgical outcomes in eye care.
Who are the top competitors of Radiance Therapeutics?
Radiance Therapeutics's top competitors include ViaLase, ELIOS Vision and BELKIN Vision.